Showing results (141-150 of 150) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group TrialS K Quella, C L Loprinzi, D L Barton, et al.The American Journal of Tropical Medicine and Hygiene|May 1, 1986
The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccineD B Fishbein, K W Bernard, K D Miller, et al.Breast Cancer Research and Treatment|January 1, 2022
Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and researchR Jagsi, G Mason, B A Overmoyer, et al.Clinical Immunology (Orlando, Fla.)|April 5, 2001
Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansionK D Miller, K Spooner, B R Herpin, et al.AIDS (London, England)|November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patientJ M Orenstein, M Feinberg, C Yoder, et al.Oncogene|September 12, 2017
A system for detecting high impact-low frequency mutations in primary tumors and metastasesM Anjanappa, Y Hao, E R Simpson, et al.ESMO Open|July 27, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancerR Jeselsohn, J Fu, Y Ren, et al.Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2023
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030H A Parsons, T Blewett, X Chu, et al.Pageof 15